New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery

Some radical with rectal crab whitethorn present beryllium capable to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) connected Monday approved the immunotherapy Jemperli (dostarlimab-gxly) for definite adults with rectal crab that hasn't been treated yet.